BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35382979)

  • 1. HLA-G/ILT2 signaling on the path to tolerance.
    Wang P; Greenland JR
    J Heart Lung Transplant; 2022 Jun; 41(6):852-853. PubMed ID: 35382979
    [No Abstract]   [Full Text] [Related]  

  • 2. HLA class I molecules regulate IFN-gamma production induced in NK cells by target cells, viral products, or immature dendritic cells through the inhibitory receptor ILT2/CD85j.
    Morel E; Bellón T
    J Immunol; 2008 Aug; 181(4):2368-81. PubMed ID: 18684926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human inhibitory receptor immunoglobulin-like transcript 2 amplifies CD11b+Gr1+ myeloid-derived suppressor cells that promote long-term survival of allografts.
    Zhang W; Liang S; Wu J; Horuzsko A
    Transplantation; 2008 Oct; 86(8):1125-34. PubMed ID: 18946352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G.
    Shiroishi M; Tsumoto K; Amano K; Shirakihara Y; Colonna M; Braud VM; Allan DS; Makadzange A; Rowland-Jones S; Willcox B; Jones EY; van der Merwe PA; Kumagai I; Maenaka K
    Proc Natl Acad Sci U S A; 2003 Jul; 100(15):8856-61. PubMed ID: 12853576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway.
    Gregori S; Tomasoni D; Pacciani V; Scirpoli M; Battaglia M; Magnani CF; Hauben E; Roncarolo MG
    Blood; 2010 Aug; 116(6):935-44. PubMed ID: 20448110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of HLA-G in maternal-fetal immune tolerance.
    Rouas-Freiss N; Khalil-Daher I; Marchal-Bras Goncalves R; Menier C; Dausset J; Carosella ED
    Transplant Proc; 1999; 31(1-2):724-5. PubMed ID: 10083309
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of iNKT Cells by the HLA-G-ILT2 Checkpoint and Poor Stimulation by HLA-G-Expressing Tolerogenic DC.
    Wu CL; Caumartin J; Amodio G; Anna F; Loustau M; Gregori S; Langlade-Demoyen P; LeMaoult J
    Front Immunol; 2020; 11():608614. PubMed ID: 33505397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolerance signaling molecules.
    Clark DA
    Chem Immunol Allergy; 2005; 89():36-48. PubMed ID: 16129951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ILT2/HLA-G interaction impairs NK-cell functions through the inhibition of the late but not the early events of the NK-cell activating synapse.
    Favier B; Lemaoult J; Lesport E; Carosella ED
    FASEB J; 2010 Mar; 24(3):689-99. PubMed ID: 19841038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-G up-regulates ILT2, ILT3, ILT4, and KIR2DL4 in antigen presenting cells, NK cells, and T cells.
    LeMaoult J; Zafaranloo K; Le Danff C; Carosella ED
    FASEB J; 2005 Apr; 19(6):662-4. PubMed ID: 15670976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerance and the fetal graft.
    Innes A; Cunningham C; Power D; Catto G
    Lancet; 1990 Nov; 336(8723):1133. PubMed ID: 1978011
    [No Abstract]   [Full Text] [Related]  

  • 12. HLA-G and HLA-E: fundamental and pathophysiological aspects.
    Carosella ED; Paul P; Moreau P; Rouas-Freiss N
    Immunol Today; 2000 Nov; 21(11):532-4. PubMed ID: 11221681
    [No Abstract]   [Full Text] [Related]  

  • 13. HLA-G and immune tolerance in pregnancy.
    Hunt JS; Petroff MG; McIntire RH; Ober C
    FASEB J; 2005 May; 19(7):681-93. PubMed ID: 15857883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-G: what's new?
    Le Bouteiller P
    Am J Reprod Immunol; 1997 Sep; 38(3):146-9. PubMed ID: 9325484
    [No Abstract]   [Full Text] [Related]  

  • 15. Rescuing lymphocytes from HLA-G immunosuppressive effects mediated by the tumor microenvironment.
    Wu D; Kuiaste I; Moreau P; Carosella E; Yotnda P
    Oncotarget; 2015 Nov; 6(35):37385-97. PubMed ID: 26460949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A homodimeric complex of HLA-G on normal trophoblast cells modulates antigen-presenting cells via LILRB1.
    Apps R; Gardner L; Sharkey AM; Holmes N; Moffett A
    Eur J Immunol; 2007 Jul; 37(7):1924-37. PubMed ID: 17549736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity.
    Wiendl H; Feger U; Mittelbronn M; Jack C; Schreiner B; Stadelmann C; Antel J; Brueck W; Meyermann R; Bar-Or A; Kieseier BC; Weller M
    Brain; 2005 Nov; 128(Pt 11):2689-704. PubMed ID: 16123145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural killer cells fertile with receptors for HLA-G?
    Lanier LL
    Proc Natl Acad Sci U S A; 1999 May; 96(10):5343-5. PubMed ID: 10318882
    [No Abstract]   [Full Text] [Related]  

  • 19. Could the functional expression of HLA-G be exploited for successful stem cell transplantation and engraftment?
    Williams MA
    J Hematother Stem Cell Res; 2003 Dec; 12(6):757-8. PubMed ID: 14977484
    [No Abstract]   [Full Text] [Related]  

  • 20. The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells.
    Navarro F; Llano M; Bellón T; Colonna M; Geraghty DE; López-Botet M
    Eur J Immunol; 1999 Jan; 29(1):277-83. PubMed ID: 9933109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.